Correlation Between Nyxoah and Telix Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nyxoah and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nyxoah and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nyxoah and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Nyxoah and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nyxoah with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nyxoah and Telix Pharmaceuticals.

Diversification Opportunities for Nyxoah and Telix Pharmaceuticals

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Nyxoah and Telix is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Nyxoah and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Nyxoah is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nyxoah are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Nyxoah i.e., Nyxoah and Telix Pharmaceuticals go up and down completely randomly.

Pair Corralation between Nyxoah and Telix Pharmaceuticals

Given the investment horizon of 90 days Nyxoah is expected to under-perform the Telix Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Nyxoah is 1.02 times less risky than Telix Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Telix Pharmaceuticals Limited is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  1,515  in Telix Pharmaceuticals Limited on September 18, 2024 and sell it today you would earn a total of  67.00  from holding Telix Pharmaceuticals Limited or generate 4.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy34.92%
ValuesDaily Returns

Nyxoah  vs.  Telix Pharmaceuticals Limited

 Performance 
       Timeline  
Nyxoah 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nyxoah has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Nyxoah is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Telix Pharmaceuticals 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Telix Pharmaceuticals Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile essential indicators, Telix Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Nyxoah and Telix Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nyxoah and Telix Pharmaceuticals

The main advantage of trading using opposite Nyxoah and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nyxoah position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.
The idea behind Nyxoah and Telix Pharmaceuticals Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios